Technology
95% Accuracy in clinical tests
McKareâ„¢ is an IoT-based healthcare device
with its 95% proven accuracy performance
compared to medical devices in numerous
clinical tests.
McKareâ„¢ uses micro-frequency radar and
micro-Doppler processing technology which
allows high-precision performance to measure,
collect and analyze user’s vital signs in real-time.
PRODUCTS
Non-contact vital signs monitoring radar sensor
2021 . 11 . 04
JCFTechnology presents a new paradigm of non-face-to-face healthcare
KOREA ECONOMY TV 2021.11.02McKare, bio-radar sensor surprised the world The Dubai Information and Communication Expo (GITEX GLOBAL x AI), one of the world's three major IT expositions, was held at the Dubai World Trade Center on the 17th of last month. JCFTechnology, a domestic startup company that developed personal health information solutions using big data and non-face-to-face, non-contact biometric information acquisition based on radar sensors, attracted attention by participating in 'GITEX Future Stars 2021'. In the market environment where similar products and solutions are being developed using radar sensors provided by radar chipset manufacturers, JCFTechnology has successfully commercialized with its self-developed core technology, from radar sensors to biosignal processing architectures to solution algorithm using big data. As such, JCFTechnology owns technology that can go beyond the limitations of the chipset and quickly optimize for the various requirements of the market. JCFTechnology which participated in GITEX Future Stars 2021 with proven products and technologies in Korea, installed an experience zone where buyers can experience and evaluate the functions and performance of biosensors and has surprised the event organizers by consulting with total of about 110 teams.Substantial consultations on product supply are held on site with big buyers from Dubai, Qatar, Egypt, India, Canada, France, etc and 3 basic contract related to product supply were written on site. The phenomenon attracted the attention of visitors and it is rare for the start-up company to get such spotlight. In an interview, Jimyung Kim, CEO of JCFTechnology said, "I was surprised that the global interest in non-contact bio-radar-based healthcare solutions is greater than expected. The common opinion of buyers is that this is the first time seeing a product that is needed in the market but realized through commercialization. Thanks to this, we will continue to strive for global advancement so that we can become a leader in the global market."In cooperation with B2G operators such as government agencies, local governments, and public institutions, bio-radar sensors are installed in facilities for the elderly, disabled people, nursing hospitals, and welfare facilities nationwide to provide information services.In addition, this year, while attracting investment from InfoBank, it was selected for the TIPS start-up company program to further strengthen its commercialization capabilities. Detailed product and technology details can be found on the JCFTechnology website. https://www.wowtv.co.kr/NewsCenter/News/Read?articleId=A202111020276&t=NN​​​​​​​​​